Conghui Ji

Title: Conghui Ji: Innovator in Pharmaceutical Chemistry

Introduction

Conghui Ji is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a focus on protein kinase inhibitors, his work has the potential to impact cancer treatment and inflammation therapies.

Latest Patents

Conghui Ji holds 2 patents related to benzoheterocyclic compounds. His latest patents disclose compounds of formula (I) and pharmaceutically accepted salts and prodrugs thereof. These compounds serve as protein kinase inhibitors, especially targeting Mek, which are useful in treating cancers and inflammation in mammals. The patents also detail treatment methods for these conditions and pharmaceutical compositions that include the described compounds. Additionally, the preparation of benzoheterocyclic compounds and potential drug candidates, such as benzooxazol, benzothiazol, and benzothiadiazol, are disclosed.

Career Highlights

Conghui Ji is currently associated with Shanghai Kechow Pharma, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for serious health conditions.

Collaborations

Some of his notable coworkers include Hongqi Tian and Chunlei Liu, who contribute to the collaborative efforts in research and development at Shanghai Kechow Pharma, Inc.

Conclusion

Conghui Ji's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the field. His work promises to advance treatment options for cancer and inflammation, showcasing the importance of innovation in healthcare.